In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor.
XM323 represents a novel class of potent inhibitors of human immunodeficiency virus (HIV) protease. In vitro studies have shown that inhibition of this enzyme translates into potent inhibition of replication of HIV type 1 (HIV-1) and HIV-2. The inhibition of virus replication was assessed with three...
Сохранить в:
| Опубликовано в:: | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology (ASM)
1993
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192753/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8109924/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.12.2606 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
